Refine
Language
- English (114)
Has Fulltext
- yes (114)
Is part of the Bibliography
- no (114)
Keywords
- e +-e − Experiments (8)
- Particle and Resonance Production (4)
- Spectroscopy (4)
- Exotics (3)
- Quarkonium (3)
- BESIII (2)
- Charm Physics (2)
- 900 GeV (1)
- ALICE (1)
- Born cross section measurement (1)
Institute
Using 448 million ψ(2S) events, the spin-singlet P-wave charmonium state hc(11P1) is studied via the ψ(2S)→π0hc decay followed by the hc→γηc transition. The branching fractions are measured to be BInc(ψ(2S)→π0hc)×BTag(hc→γηc)=(4.17+0.27−0.25±0.19)×10−4 , BInc(ψ(2S)→π0hc)=(7.23±0.33±0.38)×10−4, and BTag(hc→γηc)=(57.66+3.62−3.50±0.58)%, where the uncertainties are statistical and systematic, respectively. The hc(11P1) mass and width are determined to be M=(3525.32±0.06±0.15) MeV/c2 and Γ=(0.78+0.27−0.24±0.12) MeV. Using the center of gravity mass of the three χcJ(13PJ) mesons (M(c.o.g.)), the 1P hyperfine mass splitting is estimated to be Δhyp=M(hc)−M(c.o.g.)=(0.03±0.06±0.15) MeV/c2, which is consistent with the expectation that the 1P hyperfine splitting is zero at the lowest-order.
Using 448 million ψ(2S) events, the spin-singlet P-wave charmonium state hc(11P1) is studied via the ψ(2S)→π0hc decay followed by the hc→γηc transition. The branching fractions are measured to be BInc(ψ(2S)→π0hc)×BTag(hc→γηc)=(4.22+0.27−0.26±0.19)×10−4 , BInc(ψ(2S)→π0hc)=(7.32±0.34±0.41)×10−4, and BTag(hc→γηc)=(57.66+3.62−3.50±0.58)%, where the uncertainties are statistical and systematic, respectively. The hc(11P1) mass and width are determined to be M=(3525.32±0.06±0.15) MeV/c2 and Γ=(0.78+0.27−0.24±0.12) MeV. Using the center of gravity mass of the three χcJ(13PJ) mesons (M(c.o.g.)), the 1P hyperfine mass splitting is estimated to be Δhyp=M(hc)−M(c.o.g.)=(0.03±0.06±0.15) MeV/c2, which is consistent with the expectation that the 1P hyperfine splitting is zero at the lowest-order.
We study the direct production of the JPC=1++ charmonium state χc1(1P) in electron-positron annihilation by carrying out an energy scan around the mass of the χc1(1P). The data were collected with the BESIII detector at the BEPCII collider. An interference pattern between the signal process e+e−→χc1(1P)→γJ/ψ→γμ+μ− and the background processes e+e−→γISRJ/ψ→γISRμ+μ− and e+e−→γISRμ+μ− are observed by combining all the data samples. The χc1(1P) signal is observed with a significance of 5.1σ. This is the first observation of a C-even state directly produced in e+e− annihilation. The electronic width of the χc1(1P) resonance is determined to be Γee=(0.12+0.13−0.08) eV, which is of the same order of magnitude as theoretical calculations.
We study the direct production of the JPC=1++ charmonium state χc1(1P) in electron-positron annihilation by carrying out an energy scan around the mass of the χc1(1P). The data was collected with the BESIII detector at the BEPCII collider. An interference pattern between the signal process e+e−→χc1(1P)→γJ/ψ→γμ+μ− and the background processes e+e−→γISRJ/ψ→γISRμ+μ− and e+e−→γISRμ+μ− is observed by combining all the data samples. The χc1(1P) signal is observed with a significance of 5.1σ. This is the first observation of a C-even state directly produced in e+e− annihilation. The electronic width of the χc1(1P) resonance is determined to be Γee=(0.12+0.13−0.08) eV, which is of the same order of magnitude as theoretical calculations.
We study the direct production of the JPC=1++ charmonium state χc1(1P) in electron-positron annihilation by carrying out an energy scan around the mass of the χc1(1P). The data were collected with the BESIII detector at the BEPCII collider. An interference pattern between the signal process e+e−→χc1(1P)→γJ/ψ→γμ+μ− and the background processes e+e−→γISRJ/ψ→γISRμ+μ− and e+e−→γISRμ+μ− are observed by combining all the data samples. The χc1(1P) signal is observed with a significance of 5.1σ. This is the first observation of a C-even state directly produced in e+e− annihilation. The electronic width of the χc1(1P) resonance is determined to be Γee=(0.12+0.13−0.08) eV, which is of the same order of magnitude as theoretical calculations.
The Born cross section of the process e+e−→ηJ/ψ at a center-of-mass energy s√=3.773 GeV is measured to be (8.89±0.88±0.42) pb, using a data sample collected with the BESIII detector operating at the BEPCII storage ring. The decay ψ(3770)→ηJ/ψ is observed for the first time with a statistical significance of 7.4σ. From a fit to the dressed cross-section line-shape of e+e−→ηJ/ψ from s√=3.773 to 4.600 GeV we obtain the branching fraction of the decay ψ(3770)→ηJ/ψ to be (11.6±6.1±1.0)×10−4 when the ψ(3770) decay amplitude is added coherently to the other contributions, and (7.9±1.0±0.7)×10−4 when it is added incoherently. Here the first uncertainties are statistical and the second are systematic.
Using a data sample collected with the BESIII detector operating at the BEPCII storage ring, the Born cross section of the process 𝑒+𝑒−→𝜂𝐽/𝜓 at a center-of-mass energy √𝑠=3.773 GeV is measured to be (8.88±0.87±0.42) pb. We fit the cross section line shape before correcting for the initial state radiation from √𝑠=3.773 to 4.600 GeV to obtain the branching fraction ℬ(𝜓(3770)→𝜂𝐽/𝜓). We obtain ℬ(𝜓(3770)→𝜂𝐽/𝜓)=(11.3±5.9±1.1)×10−4 when the 𝜓(3770) decay amplitude is added coherently to the other contributions, and (8.7±1.0±0.8)×10−4 when it is added incoherently. Here the quoted uncertainties are statistical and systematic, respectively. In both cases, the statistical significance of 𝜓(3770) resonance is above 7𝜎. This is the first time the decay 𝜓(3770)→𝜂𝐽/𝜓 is observed with a statistical significance greater than 5𝜎.
We report a search for a dark photon using 14.9~fb−1 of e+e− annihilation data taken at center-of-mass energies from 4.13 to 4.60~GeV with the BESIII detector operated at the BEPCII storage ring. The dark photon is assumed to be produced in the radiative annihilation process of e+e− and to predominantly decay into light dark matter particles, which escape from the detector undetected. The mass range from 1.5 to 2.9~GeV is scanned for the dark photon candidate, and no significant signal is observed. The mass dependent upper limits at the 90% confidence level on the coupling strength parameter ϵ for a dark photon coupling with an ordinary photon vary between 1.6×10−3 and 5.7×10−3.
We search for an axion-like particle (ALP) a through the process ψ(3686)→π+π−J/ψ, J/ψ→γa, a→γγ in a data sample of (2.71±0.01)×109 ψ(3686) events collected by the BESIII detector. No significant ALP signal is observed over the expected background, and the upper limits on the branching fraction of the decay J/ψ→γa and the ALP-photon coupling constant gaγγ are set at 95% confidence level in the mass range of 0.165≤ma≤2.84GeV/c2. The limits on B(J/ψ→γa) range from 8.3×10−8 to 1.8×10−6 over the search region, and the constraints on the ALP-photon coupling are the most stringent to date for 0.165≤ma≤1.468GeV/c2.
Background: Alzheimer's disease is a common debilitating dementia with known heritability, for which 20 late onset susceptibility loci have been identified, but more remain to be discovered. This study sought to identify new susceptibility genes, using an alternative gene-wide analytical approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 m genotypes from 25,580 Alzheimer's cases and 48,466 controls.
Principal findings: In addition to earlier reported genes, we detected genome-wide significant loci on chromosomes 8 (TP53INP1, p = 1.4×10−6) and 14 (IGHV1-67 p = 7.9×10−8) which indexed novel susceptibility loci.
Significance: The additional genes identified in this study, have an array of functions previously implicated in Alzheimer's disease, including aspects of energy metabolism, protein degradation and the immune system and add further weight to these pathways as potential therapeutic targets in Alzheimer's disease.
Bipolar disorder (BD) is a highly heritable neuropsychiatric disease characterized by recurrent episodes of mania and depression. BD shows substantial clinical and genetic overlap with other psychiatric disorders, in particular schizophrenia (SCZ). The genes underlying this etiological overlap remain largely unknown. A recent SCZ genome wide association study (GWAS) by the Psychiatric Genomics Consortium identified 128 independent genome-wide significant single nucleotide polymorphisms (SNPs). The present study investigated whether these SCZ-associated SNPs also contribute to BD development through the performance of association testing in a large BD GWAS dataset (9747 patients, 14278 controls). After re-imputation and correction for sample overlap, 22 of 107 investigated SCZ SNPs showed nominal association with BD. The number of shared SCZ-BD SNPs was significantly higher than expected (p = 1.46x10-8). This provides further evidence that SCZ-associated loci contribute to the development of BD. Two SNPs remained significant after Bonferroni correction. The most strongly associated SNP was located near TRANK1, which is a reported genome-wide significant risk gene for BD. Pathway analyses for all shared SCZ-BD SNPs revealed 25 nominally enriched gene-sets, which showed partial overlap in terms of the underlying genes. The enriched gene-sets included calcium- and glutamate signaling, neuropathic pain signaling in dorsal horn neurons, and calmodulin binding. The present data provide further insights into shared risk loci and disease-associated pathways for BD and SCZ. This may suggest new research directions for the treatment and prevention of these two major psychiatric disorders.
Background: The potential anti-cancer effects of mammalian target of rapamycin (mTOR) inhibitors are being intensively studied. To date, however, few randomised clinical trials (RCT) have been performed to demonstrate anti-neoplastic effects in the pure oncology setting, and at present, no oncology endpoint-directed RCT has been reported in the high-malignancy risk population of immunosuppressed transplant recipients. Interestingly, since mTOR inhibitors have both immunosuppressive and anti-cancer effects, they have the potential to simultaneously protect against immunologic graft loss and tumour development. Therefore, we designed a prospective RCT to determine if the mTOR inhibitor sirolimus can improve hepatocellular carcinoma (HCC)-free patient survival in liver transplant (LT) recipients with a pre-transplant diagnosis of HCC. Methods: The study is an open-labelled, randomised, RCT comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing LT for HCC. Patients with a histologically confirmed HCC diagnosis are randomised into 2 groups within 4-6 weeks after LT; one arm is maintained on a centre-specific mTOR-inhibitor-free immunosuppressive protocol and the second arm is maintained on a centre-specific mTOR-inhibitor-free immunosuppressive protocol for the first 4-6 weeks, at which time sirolimus is initiated. A 3-year recruitment phase is planned with a 5-year follow-up, testing HCC-free survival as the primary endpoint. Our hypothesis is that sirolimus use in the second arm of the study will improve HCC-free survival. The study is a non-commercial investigator-initiated trial (IIT) sponsored by the University Hospital Regensburg and is endorsed by the European Liver and Intestine Transplant Association; 13 countries within Europe, Canada and Australia are participating. Discussion: If our hypothesis is correct that mTOR inhibition can reduce HCC tumour growth while simultaneously providing immunosuppression to protect the liver allograft from rejection, patients should experience less post-transplant problems with HCC recurrence, and therefore could expect a longer and better quality of life. A positive outcome will likely change the standard of posttransplant immunosuppressive care for LT patients with HCC. (trial registered at www.clinicaltrials.gov: NCT00355862) (EudraCT Number: 2005-005362-36)
The desensitized channelrhodopsin-2 photointermediate contains 13 -cis, 15 -syn retinal Schiff base
(2021)
Channelrhodopsin-2 (ChR2) is a light-gated cation channel and was used to lay the foundations of optogenetics. Its dark state X-ray structure has been determined in 2017 for the wild-type, which is the prototype for all other ChR variants. However, the mechanistic understanding of the channel function is still incomplete in terms of structural changes after photon absorption by the retinal chromophore and in the framework of functional models. Hence, detailed information needs to be collected on the dark state as well as on the different photointermediates. For ChR2 detailed knowledge on the chromophore configuration in the different states is still missing and a consensus has not been achieved. Using DNP-enhanced solid-state MAS NMR spectroscopy on proteoliposome samples, we unambiguously determined the chromophore configuration in the desensitized state, and we show that this state occurs towards the end of the photocycle.
The Compressed Baryonic Matter (CBM) experiment is a dedicated heavy ion collision experiment at the FAIR facility. It will be one of the first HEP experiments which works in a triggerless mode: data received in the DAQ from the detectors will not be associated with events by a hardware trigger anymore. All raw data within a giventime period will be collected continuously in containers, so-called time-slices. The task of the reconstruction algorithms is to create events out of this raw data stream. In this contribution, the optimization of the reconstruction software in the RICH detector to the free-streaming data flow is presented. The implementation of ring reconstruction algorithms which use time measurements of the hits as an additional parameter is discussed.